Persistent Atrial Fibrillation is Associated with Inability to Recover Atrial Contractility after MAZE IV Surgery in Rheumatic Disease

被引:11
|
作者
Tinetti, Matias [1 ]
Costello, Ramiro
Cardenas, Cesar
Piazza, Antonio
Iglesias, Ricardo
Baranchuk, Adrian [2 ]
机构
[1] Sanat Trinidad Palermo, Dept Cardiol & Echocardiog, Div Cardiol, Buenos Aires, DF, Argentina
[2] Queens Univ, Heart Rhythm Serv, Kingston Gen Hosp, Kingston, ON, Canada
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2012年 / 35卷 / 08期
关键词
atrial fibrillation; MAZE surgery; rheumatic disease; atrial contractility; RHYTHM MANAGEMENT; CARDIOMYOPATHY; EFFICACY; IMPACT;
D O I
10.1111/j.1540-8159.2012.03458.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: MAZE IV surgery is effective in restoring sinus rhythm (SR) and atrial contraction (AC) in patients with nonrheumatic persistent atrial fibrillation (AF). However, there is less information on its effectiveness to restore AC in patients with rheumatic disease. Aims: To assess the effectiveness of the MAZE IV surgery in restoring AC in patients with rheumatic disease and long persistent AF. Methods: Prospective, consecutive study in patients who underwent cardiovascular surgery and had long persistent AF in whom MAZE IV surgery was performed. The presence of AC was assessed by lateral mitral annulus tissue Doppler. Results: A total of 75 patients were included. Mean age 60 years (+/-11.7); 27 men (36%). AF duration was 63 months (+/- 34.1). Primary indication for surgery: rheumatic mitral stenosis 67 patients and mitral insufficiency eight patients. Mean left ventricular ejection fraction (LVEF) was 51.8% (+/-12.1) and mean left atrial area was 37 cm2 (+/-10.3). After a mean follow-up of 28 months (+/-9.3), 69 patients remained alive and 59 were in SR. AC was detected in 37.3% (Group A) and absent in 62.7% (Group B). The mean difference between groups was the high prevalence of AF longer than 5 years in group B (P = 0.000001). There were no differences related to left atrial size, LVEF, and age. Conclusions: In patients with rheumatic disease, the absence of correlation between SR recovery and AC recovery post MAZE IV surgery is significant. A history of long persistent AF lasting more than 5 years was a strong predictor for the absence of AC. (PACE 2012; 35:999-1004)
引用
收藏
页码:999 / 1004
页数:6
相关论文
共 50 条
  • [1] Rheumatic Disease and Atrial Fibrillation Duration Are Predictors of Inability to Recover Atrial Contractility After MAZE IV Surgery.
    Tinetti, Matias
    Costello, Ramiro
    Piazza, Antonio
    Baranchuk, Adrian
    Iglesias, Ricardo
    CIRCULATION, 2010, 122 (21)
  • [2] Risk Factors in Recurrence of Atrial Fibrillation After the Cox-Maze IV Procedure "Without Exception" for Persistent Atrial Fibrillation
    Takagaki, Masami
    Yamaguchi, Hiroki
    Ikeda, Naoko
    Nakamura, Hiromasa
    Mitsuyama, Shinichi
    Kadowaki, Tasuku
    Ueno, Yousuke
    Kataoka, Hiroshi
    Aoki, Tomoyuki
    Uchida, Takaki
    CIRCULATION, 2018, 138
  • [3] Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation Undergoing Valve Surgery
    Yang, Hui
    Zou, Pu
    He, Yuhu
    Huang, Lingzhi
    Zhou, Xinmin
    Liu, Liming
    Liu, Zhenjiang
    Zhou, Shenghua
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 6 (03) : 135 - 145
  • [4] The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation
    Engelsgaard, Camilla Skals
    Pedersen, Kenneth Bruun
    Riber, Lars Peter
    Pallesen, Peter Appel
    Brandes, Axel
    IJC HEART & VASCULATURE, 2018, 19 : 20 - 26
  • [5] Late outcomes after the Cox maze IV procedure for atrial fibrillation
    Henn, Matthew C.
    Lancaster, Timothy S.
    Miller, Jacob R.
    Sinn, Laurie A.
    Schuessler, Richard B.
    Moon, Marc R.
    Melby, Spencer J.
    Maniar, Hersh S.
    Damiano, Ralph J., Jr.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (05) : 1168 - +
  • [6] Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation
    Simon, Judit
    El Mahdiui, Mohammed
    Smit, Jeff M.
    Szaraz, Lili
    van Rosendael, Alexander R.
    Herczeg, Szilvia
    Zsarnoczay, Emese
    Nagy, Aniko Ilona
    Kolossvary, Marton
    Szilveszter, Balint
    Szegedi, Nandor
    Nagy, Klaudia Vivien
    Tahin, Tamas
    Geller, Laszlo
    van der Geest, Rob J.
    Bax, Jeroen J.
    Maurovich-Horvat, Pal
    Merkely, Bela
    CLINICAL CARDIOLOGY, 2022, 45 (03) : 273 - 281
  • [7] Surgery of persistent and permanent atrial fibrillation
    Maroto-Castellanos, Luis C.
    Perez-Villacastin, Julian
    CIRUGIA CARDIOVASCULAR, 2010, 17 (02): : 189 - 199
  • [8] Atrial Fibrillation in Rheumatic Heart Disease
    Bansal, Ankit
    Sarkar, Prattay Guha
    Chaturvedi, Vivek
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2020, 22 (11)
  • [9] Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
    Connolly, S. J.
    Karthikeyan, G.
    Ntsekhe, M.
    Haileamlak, A.
    El Sayed, A.
    El Ghamrawy, A.
    Damasceno, A.
    Avezum, A.
    Dans, A. M. L.
    Gitura, B.
    Hu, D.
    Kamanzi, E. R.
    Maklady, F.
    Fana, G.
    Gonzalez-Hermosillo, J. A.
    Musuku, J.
    Kazmi, K.
    Zuhlke, L.
    Gondwe, L.
    Ma, C.
    Paniagua, M.
    Ogah, O. S.
    Molefe-Baikai, O. J.
    Lwabi, P.
    Chillo, P.
    Sharma, S. K.
    Cabral, T. T. J.
    Tarhuni, W. M.
    Benz, A.
    van Eikels, M.
    Krol, A.
    Pattath, D.
    Balasubramanian, K.
    Rangarajan, S.
    Ramasundarahettige, C.
    Mayosi, B.
    Yusuf, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11) : 978 - 988
  • [10] Atrial Fibrillation in Rheumatic Heart Disease
    Ankit Bansal
    Prattay Guha Sarkar
    Vivek Chaturvedi
    Current Treatment Options in Cardiovascular Medicine, 2020, 22